SRTS Stock Analysis: Buy, Sell, or Hold?
SRTS - Sensus Healthcare, Inc
$4.20
0.00 (-0.12%)
▼
5d:
+4.61%
30d:
-4.88%
90d:
+5.4%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 21, 2026
Get Alerted When SRTS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SRTS appears deeply undervalued. Market expects -37.4% annual earnings decline despite 433% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: SRTS appears deeply undervalued. Market expects -37.4% annual earnings decline despite 433% recent earnings growth. Contrarian opportunity at discount to historical valuation.
In-depth Analysis How we analyze
Valuation Analysis: SRTS is currently trading at $4.20, which is considered slightly high relative to its 30-day fair value range of $3.88 to $4.30. From a valuation perspective, the stock is trading at a discount (Forward PE: 66.3) compared to its historical average (270.9). Remarkably, the market is currently pricing in an annual earnings decline of 37.4% over the next few years. This pessimistic expectation contrasts with the company's recent 433.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SRTS is showing sideways momentum. Immediate support is located at $3.76, while resistance sits at $4.55.
Market Sentiment: SRTS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.88 (+63.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SRTS is showing sideways momentum. Immediate support is located at $3.76, while resistance sits at $4.55.
Market Sentiment: SRTS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.88 (+63.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$3.88 -
$4.30
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 63.7% below Wall St target ($6.88)
Fair Price Analysis
30-Day Fair Range
$3.88 -
$4.30
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.76
Resistance Level
$4.55
Current Trend
Sideways
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
66.35
Wall Street Target
$6.88
(+63.7%)
Revenue Growth (YoY)
155.7%
Earnings Growth (YoY)
433.3%
Profit Margin
-28.1%
Valuation Discount vs History
-37.4% cheaper
PE vs Historical
66.4 vs 270.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-37.4%
(market-implied from PE analysis)
1-Year Target
$3.78
(-10%)
2-Year Target
$3.40
(-19%)
3-Year Target
$3.06
(-27%)
3-Yr Target (if PE normalizes)
(PE: 66→271)
$12.50
(+198%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 66.4 to 270.9
Stabilization Target:
$17.15
(+308.3%)
PE Expansion Potential:
+308.3%
Share & Embed Analysis
Last updated: April 02, 2026 2:27 PM ET
Data refreshes hourly during market hours. Next update: 3:27 PM
Data refreshes hourly during market hours. Next update: 3:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRTS showing a specific setup today?
Insider Activity (6 Months)
6
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Eric Sachetta
BUY
2000 shares
2026-02-24
Eric Sachetta
BUY
7000 shares
2025-11-21
Joseph C Sardano
BUY
25000 shares
2025-11-18
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 56 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$93 | 62 BUY |
Advanced SRTS Option Strategies
Professional options setups generated by AI based on today's SRTS price and gamma walls.
